about
Immune response to 2009 pandemic H1N1 influenza virus A monovalent vaccine in children with cancer.Clinical features, prognostic factors, and their relationship with antiplatelet antibodies in children with immune thrombocytopenia.Clinical features and major histocompatibility complex genes as potential susceptibility factors in pediatric immune thrombocytopenia.Successful treatment of Kasabach-Merritt phenomenon with intralesional corticosteroid injections: a case series.Leukemia inhibitory factor regulates trophoblast giant cell differentiation via Janus kinase 1-signal transducer and activator of transcription 3-suppressor of cytokine signaling 3 pathway.Expression and prognostic significance of the apoptotic genes BCL2L13, Livin, and CASP8AP2 in childhood acute lymphoblastic leukemia.Essential, nonredundant role for the phosphoinositide 3-kinase p110delta in signaling by the B-cell receptor complex.GALNT2 suppresses malignant phenotypes through IGF-1 receptor and predicts favorable prognosis in neuroblastoma.A Double Negative Loop Comprising ETV6/RUNX1 and MIR181A1 Contributes to Differentiation Block in t(12;21)-Positive Acute Lymphoblastic Leukemia.The long-term efficacy and tolerability of oral deferasirox for patients with transfusion-dependent β-thalassemia in Taiwan.Diagnostic FDG and FDOPA positron emission tomography scans distinguish the genomic type and treatment outcome of neuroblastoma.A case of natural killer cell lymphoma presenting with bilateral pleural effusions and hemophagocytic lymphohistocytosis.Spatial repolarization heterogeneity detected by magnetocardiography correlates with cardiac iron overload and adverse cardiac events in beta-thalassemia major.A multidisciplinary team care approach improves outcomes in high-risk pediatric neuroblastoma patients.Rescue of cardiopulmonary collapse in anterior mediastinal tumor: case presentation and review of literature.Improved efficacy and tolerability of oral deferasirox by twice-daily dosing for patients with transfusion-dependent β-thalassemia.Systematic review and meta-analysis of nonpharmacological interventions for fatigue in children and adolescents with cancer.β-1,4-Galactosyltransferase III enhances invasive phenotypes via β1-integrin and predicts poor prognosis in neuroblastoma.The Mediating Role of Resilience on Quality of Life and Cancer Symptom Distress in Adolescent Patients With Cancer.Absence of biallelic TCRγ deletion predicts induction failure and poorer outcomes in childhood T-cell acute lymphoblastic leukemia.IKZF1 deletions predict a poor prognosis in children with B-cell progenitor acute lymphoblastic leukemia: a multicenter analysis in Taiwan.Infectious complications in children with acute lymphoblastic leukemia treated with the Taiwan Pediatric Oncology Group protocol: A 16-year tertiary single-institution experience.Search of Unknown Fever Focus Using PET in Critically Ill Children With Complicated Underlying Diseases.Clinical characteristics and outcome of invasive fungal infections in pediatric acute myeloid leukemia patients in a medical center in Taiwan.Differentiating juvenile myelomonocytic leukemia from chronic myeloid leukemia in childhood.Long-term outcome for Down syndrome patients with hematopoietic disorders.Risk factors and outcomes of cytomegalovirus viremia in pediatric hematopoietic stem cell transplantation patients.Tet oncogene family member 2 gene alterations in childhood acute myeloid leukemia.Severe bacterial infection in transfusion-dependent patients with thalassemia major.Prognostic roles of pathology markers immunoexpression and clinical parameters in Hepatoblastoma.Post-transplantation lymphoproliferative disorders localizing to the gastrointestinal tract after liver transplantation: report of five pediatric cases.Nephromegaly relates to hepatocyte growth factor dysregulation in biliary atresia.Cardiac iron measurement and iron chelation therapy in patients with β thalassaemia major: experience from Taiwan.Characterization of neuroblastic tumors using 18F-FDOPA PET.Cytogenetics in childhood acute lymphoblastic leukemia in Taiwan: a single-institutional experience.Forty-seven children suffering from chronic myeloid leukemia at a center over a 25-year period.Connatal tuberculosis in a very premature infant.Recombinant urate oxidase (rasburicase) for the prevention and treatment of tumor lysis syndrome in patients with hematologic malignancies.Pediatric acute lymphoblastic leukemia with t(1;19)/TCF3-PBX1 in Taiwan.Treatment for childhood acute lymphoblastic leukemia in Taiwan: Taiwan Pediatric Oncology Group ALL-2002 study emphasizing optimal reinduction therapy and central nervous system preventive therapy without cranial radiation.
P50
Q30401024-8B18FD5D-463B-456A-B88B-A7B2CCEDF24EQ33399025-49E4D501-126D-498E-9346-14F1D823E1E3Q33402462-8AA9F0B1-C55A-4D04-9FF7-FFBC1B3280CDQ33404377-C8ACE4F8-DCD7-4112-AC89-D9A88ABDAB8CQ33642687-E8C80229-41AE-430E-93EF-AC7F231E6BE0Q34095354-9500573B-96D7-4DA4-B164-266BD9233FB5Q34443608-876C4113-728B-46E0-8FB5-FA3FCA4538F6Q35067906-AB008EED-46D9-4526-A4BB-982DD05A3188Q35845024-E55258F1-2745-4F0A-8481-FFE4E797B981Q36158835-ED3608B8-4281-42AF-A368-3C9B6B531BABQ37109868-8AE3F202-291A-4EF1-8BD6-516CE6956425Q37373543-C2DFD1B6-952B-455A-9E89-1D574C569BB9Q37520798-086DD0C7-C6A3-4936-AE03-E2365C63C6A3Q37706191-64D2BE77-60F8-40D4-988A-B6D41DE09C27Q37729721-DA98580B-B0E4-4A29-8E8E-CCDE04937479Q37809009-FB5FC3D4-1FBE-4F8B-BD13-82E3A53E6A63Q38117839-1A702890-81D2-4726-B9C9-6F0BF3CDD842Q39187979-C3D9FB9B-B916-4ABD-87D8-0D158ECB8DAAQ39273415-5353694A-BA10-4ABC-91E0-BF287919E69BQ39674477-16FFE91C-B86A-440D-AE4B-5E80FF1ADF25Q39730823-7C565868-52CA-4813-8B78-5E415AA78490Q40062706-656855B2-2954-4690-984B-D6BD05E23924Q40127666-B14722DF-AEE2-45EE-A210-C415856C1E17Q40371441-12C8EDFE-1041-418B-861A-AEEE2B7CB184Q40535836-84817670-BB06-4A6E-BD3A-9DC7CD8352CDQ40669415-948240E7-05D5-4B12-91A3-1EA85903E986Q41011887-B8331F13-542A-48C2-ACB7-A34E9FE64790Q41297543-654301A5-2D45-4208-95B5-94C8598B4E4CQ41465572-08CD4DB8-03BA-4924-801A-C28908B395D6Q41542757-0D079229-C4D7-436B-86DF-F1B80296E495Q43988028-22DA862B-616A-47AD-83B3-667DD7EA1F2FQ44098085-15494D67-BD03-45D8-9124-0DFF4539CD3EQ44142481-9BB11775-69B8-42B7-B761-B25AABAF98BCQ44201943-BF6E8204-9D5F-4BEC-81DC-C565FA647351Q44516173-85CC4E50-EF29-41CE-B6AB-D6039B72FCDDQ44575935-CA17CC99-3A44-4D09-83F6-1D62BF383876Q45199730-7F5D4C9D-0B6F-4897-B899-89FB2412F8AAQ46902520-AE1796C3-2755-4C28-886A-4B85633328B0Q47908187-82F482CA-A1A4-4055-AB7C-9367E88D320AQ48039932-C7DA6ABB-C17C-4837-BD32-E24F8426DC22
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Shiann-Tarng Jou
@ast
Shiann-Tarng Jou
@en
Shiann-Tarng Jou
@es
Shiann-Tarng Jou
@nl
type
label
Shiann-Tarng Jou
@ast
Shiann-Tarng Jou
@en
Shiann-Tarng Jou
@es
Shiann-Tarng Jou
@nl
prefLabel
Shiann-Tarng Jou
@ast
Shiann-Tarng Jou
@en
Shiann-Tarng Jou
@es
Shiann-Tarng Jou
@nl
P106
P1153
56769201400
7006727791
P31
P496
0000-0003-1483-0403